LRRK2 and Parkinson disease: DEA results (Table S3) showed that: the mRNA levels of 67 interactors (17.7%) were significantly altered in the LRRK2-PD cases vs. controls, with 39 down-regulated and 28 up-regulated interactors (|log2(FC) > 0.05|, adjusted-p < 0.05, Fig. 1A, Table S3).